Compare Carvana Co (CVNA) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carvana Co vs Tenet Healthcare Corporation — how do they compare? Carvana Co trades at $63.82 (market cap $69.55B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Carvana Co is far larger — about 3.3× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Carvana Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Carvana Co for 28 Days and Tenet Healthcare Corporation for 15 Days on average.
| CVNA | THC | |
|---|---|---|
Market Cap | $69.55B | $20.98B |
Volume | 7,671,750 | 428,008 |
Sector | Consumer Cyclical | Health |
52-Week High | $95.69 | $280.77 |
52-Week Low | $56.27 | $161.37 |
Typical Hold Time | 28 Days | 15 Days |
Enterprise Value | $72.04B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Carvana (CVNA) trades at $62.76, down 1.72% on the day, amid a bearish technical signal despite strong fundamental performance. The company reported robust revenue growth, with 2025 revenue reaching $20.32B and net income of $1.41B, and has consistently beaten EPS estimates in recent quarters. Analyst consensus is mixed with a $84.07 price target, while technical indicators show resistance near $64 and support at $61.
Outlook remains cautiously optimistic given operational strength and growth trajectory, but high debt levels and competitive pressures pose risks. The stock offers upside if execution continues, yet volatility and macroeconomic factors warrant careful monitoring for investors.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Carvana Co
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.
Read more on CVNA →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
